Skip to content

Drug interactions

Tranylcypromine + Ziprasidone

Severity: Moderate

Tranylcypromine and Ziprasidone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ziprasidone has serotonergic and dopamine-blocking activity, so combining it with an MAO inhibitor raises the theoretical risk of serotonin toxicity or neuroleptic malignant syndrome. Ziprasidone also prolongs the QT interval, which adds to its own cardiac risk.

What this interaction means in plain words

Tranylcypromine and Ziprasidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Tranylcypromine belongs to Central Nervous System; Ziprasidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive pharmacodynamic effects of MAO inhibition and ziprasidone's serotonin reuptake inhibition and receptor antagonism.

What to do

Monitor for hyperthermia, rigidity, clonus and autonomic instability. Check baseline ECG and electrolytes if risk factors for QT prolongation exist.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tranylcypromine and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tranylcypromine with Ziprasidone?

MediHelp rates the interaction as moderate. Tranylcypromine and Ziprasidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ziprasidone has serotonergic and dopamine-blocking activity, so combining it with an MAO inhibitor raises the theoretical risk of serotonin toxicity or neuroleptic malignant syndrome. Ziprasidone also prolongs the QT interval, which adds to its own cardiac risk.

How serious is the interaction between Tranylcypromine and Ziprasidone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for hyperthermia, rigidity, clonus and autonomic instability. Check baseline ECG and electrolytes if risk factors for QT prolongation exist.

What other medicines interact with Tranylcypromine?

MediHelp also lists interactions of Tranylcypromine with, for example, 5-HTP, Amitriptyline, Amoxapine. The full list is on the Tranylcypromine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in